Furthermore, preclinical data in non-small cell lung cancer (NSCLC) reported that mTOR-dependent, statin-induced inhibition of Akt phosphorylation and nuclear translocation sensitizes cells to etoposide and other cytostatic drugs which supports our clinical findings [20]. This evidence concerns the gene MTOR and non-small cell lung carcinoma.